From Neuroscience to Neurology: Neuroscience, Molecular Medicine, and the Therapeutic Transformation of Neurology

Front Cover
Elsevier, Nov 5, 2004 - Medical - 552 pages
The field of neurology is being transformed, from a therapeutically nihilistic discipline with few effective treatments, to a therapeutic specialty which offers new, effective treatments for disorders of the brain and spinal cord. This remarkable transformation has bridged neuroscience, molecular medicine, and clinical investigation, and represents a major triumph for biomedical research. This book, which contains chapters by more than 29 internationally recognized authorities who have made major contributions to neurotherapeutics, tells the stories of how new treatments for disabling disorders of the nervous system, such as stroke, multiple sclerosis, Parkinson’s disease, and migraine, were developed, and explores evolving themes and technologies that offer hope for even more effective treatments and ultimately cures for currently untreatable disorders of the brain and spinal cord.

The first part of this book reviews the development of new therapies in neurology, from their inception in terms of basic science to their introduction into the clinical world. It also explores evolving themes and new technologies. This book will be of interest to everyone – clinicians and basic scientists alike – interested in diseases of the brain and spinal cord, and in the quest for new treatments for these disorders.

* Presents the evolution of the field of neurology into a therapeutic discipline
* Discusses lessons learned from past successes and applications to ongoing work
* Explores the future of this field
 

What people are saying - Write a review

User Review - Flag as inappropriate

PROYECTO GENOCIDIO
NORTE AMERICANOS NEGRO PONTE USA EE.UU. ASESINANDO Y TORTURANDO.
OBAMA NEGRO PONTE TORTURAS DEL AREA 51 (Killing Softly) NARCOTRAFICANTES VIOLADORES ASESINOS LADRONES
LA FAMILIA BUSH NARCOTRAFICANTES VIOLADORES ASESINOS LADRONES
LA FAMILIA BILLINGER NARCOTRAFICANTES VIOLADORES ASESINOS LADRONES
NEGRO PONTE TORTURAS DEL AREA 51 (Killing Softly) NARCOTRAFICANTES VIOLADORES ASESINOS LADRONES
EL REY DE ESPAÑA CONSUME DROGAS NARCOTRAFICO DEL REY ESPAÑOL CIUDADANOS VENEZOLANOS USADOS COMO RATAS LEY ANTI MIND CONTROL TORTURAS MENTALES.
https://docs.google.com/open?id=0B7rdd1w6dkcSUF9UdExPc2hKQXM
http://twittervenezuela.co/group/carlaangolatwittervenezuela
DENUNCIA A MINISTROS CHAVISTAS HOLOCAUSTO LATINO AMERICANO Julio Cesar Pineda WWW.docs.google.com/open?id=0B7rdd1w6dkcSamZTX1ZNWWZmVkk
Universidad de Carabobo.
JUAN CARLOS VALLEJOS VZLA 04144229169
Facultad de derecho.
BRUJULA INTERNACIONAL
Lic. Julio Cesar Pineda
Lic. Mariel Sofía Rodríguez
Lic. Nitu Perez O.
PAGINA WEB: WWW.docs.google.com/open?id=0B7rdd1w6dkcSamZTX1ZNWWZmVkk
Nos comunicamos con ustedes por que entre las relaciones que tienen a nivel internacional pudiesen encontrar ayuda legal para los crimenes
que se encuentra realizando el presidente de Venezuela.
Este tipo de crimenes son conciderados como genocidio, a estas personas venezolanos les realizan cauterizaciones, radiaciones y otros tipos de deterioros.
La puebes que tenemos en niestro poder:
a. Libros.
b. Bases de datos de Casos.
c. Informaciones de venezolanos que les realizan este tipo de crimenes.
d. Videos de estas tecnologias.
e. El caso fuen enviado a Delsa Solorzano.
Por favor necesitamos urgentemente su ayuda.
DIPUTADOS:
Abelardo Díaz TAC MUD @abelardo_diaz
Alfonso Marquina MIR MUD @alfonsomarquina
Alfredo Osorio ZUL MUD @alfredoosoriou
Alfredo Ramos LAR MUD @alfredoaramos
Americo De Grazia BOL MUD @americodegrazia
Andrés Velásquez BOL MUD @andresvelasqz
Antonio Barreto MUD @barretosira
Bernardo Guerra MUD @Bernardoguerrac
Biagio Pilieri YAR MUD @biagiopilieri
Carlos B CAR MUD @ceberrizbeitia
Carlos M ANZ MUD @camichelangeli
Carlos Ramos MUD @carlose_ramos
César Rincones SUC MUD @cesar_rincones
Dennis F COJ MUD @adennisf
Deyalitza A MUD @dearay66
Dinorah F MIR MUD @dinorahfiguera
Edgar Zambrano MUD @ezambranoad
Eduardo Gómez LAR MUD @egomezsigala
Elías Matta ZUL MUD @eliasmattaw
Eliezer Sirit MUD @EliezerSirit
Enrique Catalán MUD @enriquecatalan
Enrique Márquez MUD @enriquemarquez
Enrique Mendoza MUD @enriquemendozad
Freddy Paz ZUL MUD @freddypaz
Gabino Paz TAC MUD No tiene
Gregorio G FAL MUD @goyograterol
Hermán Núñez SUC MUD @hernanjnunez
Hermes García SUC MUD No Tiene
Hernán Alemán ZUL MUD @hernanaleman10
Hiram Gaviria ARA MUD @hiramgaviria
Homero Ruiz MUD @homeroruizvivas
Ismael García MUD @ismaelpodemos28
Iván Colmenares MUD No Tiene
Jacinto Romero ANZ MUD @jacintoromero_l
Jesus Paraqueima MUD @jparaqueima
José Manuel G GUA MUD No Tiene
José “Mazuco” ZUL MUD @comisariomazuco
Juan Carlos CalderaMIR MUD @calderajuan
Juan P. García MON MUD @juan_pablog
Juan Romero ZUL MUD @juanbromero
Julio Borges MIR MUD @julioborges
Julio C. Reyes BAR MUD No Tiene
Julio Montoya ZUL MUD @juliocmontoya
Leomagno Flores MUD @leomagnofl
Marcos Figueroa MUD @marcosfigueroa
María Corina M MIR MUD @mariacorina2011
Mervin Méndez MUD @mervinmendezq
Miguel Ángel R TAC MUD @miguelcontigo
Miguel Cocchiola MUD @miguelcocchiola
Miriam de Montilla APU MUD @miriamdmontilla
Morel Rodríguez NE MUD @morelrr
Omar Barboza ZUL MUD No Tiene
Orlando Ávila MUD @orlandoaviladip
Richard Arteaga MUD @richardarteaga
Richard Blanco MUD @richardblancoc
Richard Mardo MUD @richardmardo
Rodolfo Rodríguez
 

Contents

Moving Toward The Clinic Evolving Themes and Technologies
215
Index
493
Color Plate Section
515
Copyright

Other editions - View all

Common terms and phrases

Popular passages

Page 31 - Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients.
Page 33 - Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.
Page 33 - Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators.
Page 31 - Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials.
Page 17 - Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.
Page 17 - Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Page 16 - Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

About the author (2004)

Stephen G. Waxman, MD, PhD
Chairman, Department of Neurology
Bridget Marie Flaherty Professor of Neurology, Neurobiology, & Pharmacology
Yale University School of Medicine
New Haven, CT
Chief, Neurology Service
Yale-New Haven Hospital
New Haven, CT
Visiting Professor of Neurology, Anatomy, & Biology
Institute of Neurology
University College
London, England

Bibliographic information